chlorambucil has been researched along with Cytomegalic Inclusion Disease in 8 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chlorambucil is an alkylating agent used in combination with prednisolone for the treatment of idiopathic membranous nephropathy." | 1.40 | Chlorambucil-induced cytomegalovirus infection: a case report. ( Arambarri-Segura, M; de la Nieta-García, MD; López-Lluva, MT; Martínez-Calero, A; Piqueras-Flores, J; Rivera-Hernández, F, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eketorp Sylvan, S | 1 |
| Lundin, J | 1 |
| Ipek, M | 1 |
| Palma, M | 1 |
| Karlsson, C | 1 |
| Hansson, L | 1 |
| López-Lluva, MT | 1 |
| de la Nieta-García, MD | 1 |
| Piqueras-Flores, J | 1 |
| Arambarri-Segura, M | 1 |
| Martínez-Calero, A | 1 |
| Rivera-Hernández, F | 1 |
| Gritti, G | 1 |
| Reda, G | 1 |
| Maura, F | 1 |
| Piciocchi, A | 1 |
| Baldini, L | 1 |
| Molica, S | 1 |
| Neri, A | 1 |
| Cortelezzi, A | 1 |
| HUNEYCUTT, HC | 1 |
| ANDERSON, WR | 1 |
| HENDRY, WS | 1 |
| Hasselbach, HC | 1 |
| Fickenscher, H | 1 |
| Nölle, B | 1 |
| Roider, J | 1 |
| Jongen, PJ | 1 |
| ter Laak, HJ | 1 |
| Van de Putte, LB | 1 |
| Remenyik, E | 1 |
| Ujj, G | 1 |
| Kiss, A | 1 |
| Kószó, F | 1 |
| Horkay, I | 1 |
| Kodo, H | 1 |
1 review available for chlorambucil and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Graft-versus-host disease.
Topics: Bone Marrow Transplantation; Cardiac Surgical Procedures; Chlorambucil; Cytomegalovirus Infections; | 1987 |
1 trial available for chlorambucil and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Mur | 2012 |
6 other studies available for chlorambucil and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients.
Topics: Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineopla | 2014 |
Chlorambucil-induced cytomegalovirus infection: a case report.
Topics: Aged, 80 and over; Alkylating Agents; Chlorambucil; Cytomegalovirus Infections; Glomerulonephritis, | 2014 |
PNEUMOCYSTIS CARINII PNEUMONIA. CASE STUDIES WITH ELECTRON MICROSCOPY.
Topics: Chlorambucil; Chloramphenicol; Cytomegalovirus Infections; Diagnosis, Differential; Digoxin; Electro | 1964 |
[Atypical ocular toxoplasmosis with concomitant ocular reactivation of varicella-zoster virus and cytomegalovirus in an immunocompromised host].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Chlorambucil; Chorioretinitis; Como | 2008 |
Inclusion body myositis responding to longterm chlorambucil treatment.
Topics: Chlorambucil; Cytomegalovirus Infections; Female; Humans; Middle Aged; Myositis; Time Factors | 1995 |
Porphyria cutanea tarda and chronic lymphoid leukemia.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents, Alkylating; Blood Transfusion; Chlorambucil; C | 1996 |